Drug Database
Back to search

France· FR:63839179

NEO-MERCAZOLE 5 mg, comprimé

A carbimazole product containing carbimazole, registered in France by AMDIPHARM, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC H03BB01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNEO-MERCAZOLE 5 mg, compriméATCH03BB01REGISTER NO.FR:63839179PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about carbimazoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Carbimazole is registered in 8 of 19 countries.

Countries holding a registration under ATC H03BB01 (carbimazole), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 4 of them publish a price we can compare per daily dose
Search carbimazole products by name

Carbimazole · ATC H03BB01

8 / 19 countries

  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of carbimazole costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in France to $0.94 in Switzerland — a ×6.3 gap.

  • France: $0.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Carbimazole · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.94
  • FR France$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CARBIMAZOLE
Manufacturer
AMDIPHARM
Country
France (FR)
ATC code
H03BB01
ATC class
Carbimazole
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936111066
    tube(s) polypropylène de 50 comprimé(s)
    EUR 2.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carbimazole in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbimazole products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Cyprus · Carbimazole Remedica
  • Germany · Carbimazol 1 A Pharma, Carbimazol Aristo
  • Denmark · Neo-Mercazole
  • Spain · Neo-Tomizol
  • Finland · Tyrazol
  • United Kingdom (Northern Ireland) · Carbimazole, Carbimazole Activase Pharmaceuticals
  • Greece · Thyrostat
  • Ireland · Carbimazole Essential Healthcare, Carbimazole Renata Pharmaceuticals (Ireland)
  • Malta · Carbimazole Remedica, Carbimazole Renata Pharmaceuticals (Ireland)
  • Norway · Neo-Mercazole
  • Portugal · Carbimazole Renata, Carbimazole Renata 20 Mg Comprimidos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0622db3e-3614-4cd9-888f-31b19cb05dbd
GET /v1/drugs/0622db3e-3614-4cd9-888f-31b19cb05dbd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63839179",
  "date_amm": "1997-03-28",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CARBIMAZOLE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about carbimazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console